72 related articles for article (PubMed ID: 36599598)
21. [Update of the recommendations for the determination of biomarkers in colorectal carcinoma. National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology].
Navarro S; Cuatrecasas M; Hernández-Losa J; Landolfi S; Musulén E; Ramón Y Cajal S; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; García-Alfonso P
Rev Esp Patol; 2021; 54(1):41-54. PubMed ID: 33455693
[TBL] [Abstract][Full Text] [Related]
22. [Consensus statement on biomarkers in breast cancer by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
Palacios Calvo J; Albanell J; Rojo F; Ciruelos E; Aranda-López I; Cortés J; García-Caballero T; Martín M; López-García MÁ; Colomer R
Rev Esp Patol; 2018; 51(2):97-109. PubMed ID: 29602380
[TBL] [Abstract][Full Text] [Related]
23. Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: A Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Pérez JMT; García-Cosío M; García-Castaño A; Gomà M; Mesia-Nin R; Ruiz-Bravo E; Soria-Rivas A; Castillo P; Braña-García I; Alberola-Ferranti M
Rev Esp Patol; 2023; 56(1):45-57. PubMed ID: 36599600
[TBL] [Abstract][Full Text] [Related]
24. [New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
Isla D; Lozano MD; Paz-Ares L; Salas C; de Castro J; Conde E; Felip E; Gómez-Román J; Garrido P; Belén Enguita A
Rev Esp Patol; 2023; 56(2):97-112. PubMed ID: 37061248
[TBL] [Abstract][Full Text] [Related]
25. [Recommendations for biomarker testing in epithelial ovarian cancer. A national consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
Oaknin A; Guarch R; Barretina P; Hardisson D; González-Martín A; Matías-Guiu X; Pérez-Fidalgo A; Vieites B; Romero I; Palacios J
Rev Esp Patol; 2018; 51(2):84-96. PubMed ID: 29602379
[TBL] [Abstract][Full Text] [Related]
26. [Liquid biopsy in oncology: A consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
Álvarez-Alegret R; Rojo Todo F; Garrido P; Bellosillo B; Rodríguez-Lescure Á; Rodríguez-Peralto JL; Vera R; de Álava E; García-Campelo R; Remon J
Rev Esp Patol; 2020; 53(4):234-245. PubMed ID: 33012494
[TBL] [Abstract][Full Text] [Related]
27. Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
García-Carbonero R; Vilardell F; Jiménez-Fonseca P; González-Campora R; González E; Cuatrecasas M; Capdevila J; Aranda I; Barriuso J; Matías-Guiu X; ;
Clin Transl Oncol; 2014 Mar; 16(3):243-56. PubMed ID: 23749327
[TBL] [Abstract][Full Text] [Related]
28. Rare cancer, rare alteration: the case of NTRK fusions in biliary tract cancers.
Boilève A; Verlingue L; Hollebecque A; Boige V; Ducreux M; Malka D
Expert Opin Investig Drugs; 2021 Apr; 30(4):401-409. PubMed ID: 33641556
[No Abstract] [Full Text] [Related]
29. [Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology].
López-Ríos F; Paz-Ares L; Sanz J; Isla D; Pijuan L; Felip E; Gómez-Román JJ; de Castro J; Conde E; Garrido P
Rev Esp Patol; 2020; 53(3):167-181. PubMed ID: 32650968
[TBL] [Abstract][Full Text] [Related]
30. [2018 Consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary].
Matías-Guiu X; Fusté V; Iglesias L; Balañá C; Concha Á; de la Cruz-Merino L; Nieto B; Pané M; Sanz J; Losa F
Rev Esp Patol; 2019; 52(1):33-44. PubMed ID: 30583830
[TBL] [Abstract][Full Text] [Related]
31. Updated guidelines for biomarker testing in colorectal carcinoma: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
García-Alfonso P; García-Foncillas J; Salazar R; Pérez-Segura P; García-Carbonero R; Musulén-Palet E; Cuatrecasas M; Landolfi S; Ramón Y Cajal S; Navarro S; ;
Clin Transl Oncol; 2015 Apr; 17(4):264-73. PubMed ID: 25373533
[TBL] [Abstract][Full Text] [Related]
32. Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
Colomer R; Aranda-López I; Albanell J; García-Caballero T; Ciruelos E; López-García MÁ; Cortés J; Rojo F; Martín M; Palacios-Calvo J
Clin Transl Oncol; 2018 Jul; 20(7):815-826. PubMed ID: 29273958
[TBL] [Abstract][Full Text] [Related]
33. Guidelines for HER2 testing in breast cancer: a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
Albanell J; Andreu X; Calasanz MJ; Concha A; Corominas JM; García-Caballero T; López JA; López-Ríos F; Ramón y Cajal S; Vera-Sempere FJ; Colomer R; Martín M; Alba E; González-Martín A; Llombart A; Lluch A; Palacios J
Clin Transl Oncol; 2009 Jun; 11(6):363-75. PubMed ID: 19531451
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis of pancreatico-biliary malignancy: detection of gene mutations in plasma and stool.
Mulcahy H; Farthing MJ
Ann Oncol; 1999; 10 Suppl 4():114-7. PubMed ID: 10436800
[TBL] [Abstract][Full Text] [Related]
35. Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers.
Letelier P; Riquelme I; Hernández AH; Guzmán N; Farías JG; Roa JC
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27223281
[TBL] [Abstract][Full Text] [Related]
36. Current and emerging therapies for advanced biliary tract cancers.
Kam AE; Masood A; Shroff RT
Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):956-969. PubMed ID: 34626563
[TBL] [Abstract][Full Text] [Related]
37. Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology.
Felip E; Concha Á; de Castro J; Gómez-Román J; Garrido P; Ramírez J; Isla D; Sanz J; Paz-Ares L; López-Ríos F
Clin Transl Oncol; 2015 Feb; 17(2):103-12. PubMed ID: 25351175
[TBL] [Abstract][Full Text] [Related]
38. Dilemma of elevated CA 19-9 in biliary pathology.
Tsen A; Barbara M; Rosenkranz L
Pancreatology; 2018 Dec; 18(8):862-867. PubMed ID: 30249386
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection.
Brozos-Vázquez E; Toledano-Fonseca M; Costa-Fraga N; García-Ortiz MV; Díaz-Lagares Á; Rodríguez-Ariza A; Aranda E; López-López R
Cancer Treat Rev; 2024 Apr; 125():102719. PubMed ID: 38490088
[TBL] [Abstract][Full Text] [Related]
40. Genomic Profiling of Biliary Tract Cancers and Implications for Clinical Practice.
Jain A; Kwong LN; Javle M
Curr Treat Options Oncol; 2016 Nov; 17(11):58. PubMed ID: 27658789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]